Literature DB >> 3579911

K252a, a new inhibitor of protein kinase C, concomitantly inhibits 40K protein phosphorylation and serotonin secretion in a phorbol ester-stimulated platelets.

K Yamada, K Iwahashi, H Kase.   

Abstract

K252a isolated from microbial origin was found to potently inhibit protein kinase C in vitro (1). This agent inhibits phosphorylation of 40,000 dalton protein (40K protein) induced by 12-0-tetradecanoylphorbol-13-acetate(TPA) in intact rabbit platelets. This indicates that K252a exhibits the inhibition of protein kinase C in intact cells. The serotonin secretion induced by TPA was inhibited by K252a at nearly equal concentrations required to inhibit the phosphorylation of 40K protein. This provides the evidence to support the cause-effect relationship between the protein phosphorylation and the secretion in TPA-stimulated platelets.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579911     DOI: 10.1016/s0006-291x(87)80471-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Partial purification and characterization of a Ca(2+)-dependent protein kinase from pea nuclei.

Authors:  H Li; M Dauwalder; S J Roux
Journal:  Plant Physiol       Date:  1991       Impact factor: 8.340

2.  Molecular mechanism and functional implications of thrombin-mediated tyrosine phosphorylation of PKCdelta in platelets.

Authors:  Swaminathan Murugappan; Haripriya Shankar; Surya Bhamidipati; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  Neuronal expression in cleavage-arrested ascidian blastomeres requires gap junctional uncoupling from neighbouring cells.

Authors:  M Saitoe; T Inazawa; K Takahashi
Journal:  J Physiol       Date:  1996-03-15       Impact factor: 5.182

4.  Protein kinase C activators selectively inhibit insulin-stimulated system A transport activity in skeletal muscle at a post-receptor level.

Authors:  A Gumà; M Camps; M Palacín; X Testar; A Zorzano
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

5.  Protein kinase C-dependent and -independent mechanisms regulating the parotid substance P receptor as revealed by differential effects of protein kinase C inhibitors.

Authors:  H Sugiya; J W Putney
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

6.  The effect of K-252a, a potent microbial inhibitor of protein kinase, on activated cyclic nucleotide phosphodiesterase.

Authors:  Y Matsuda; S Nakanishi; K Nagasawa; K Iwahashi; H Kase
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

7.  The H1-histamine receptor antagonist dithiaden inhibits stimulated platelet aggregation, malondialdehyde formation and thromboxane production in vitro.

Authors:  R Nosál; V Jancinová; M Petríková
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

8.  Ceramide alters endothelial cell permeability by a nonapoptotic mechanism.

Authors:  Karsten Lindner; Ulrike Uhlig; Stefan Uhlig
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

9.  Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors.

Authors:  W R Bishop; J August; J M Petrin; J K Pai
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

10.  K252a, a potent protein kinase inhibitor, improves endotoxic lethality and glucose dyshomeostasis.

Authors:  H Inaba; T Numai; M Araki; T Mizuguchi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.